Fascia Iliaca Blocks and Pre-operative Opioid Requirements in Hip Fracture Patients
NCT ID: NCT02804542
Last Updated: 2023-09-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
29 participants
OBSERVATIONAL
2016-08-11
2019-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Analgesia for Positioning Hip Fracture Patients for Spinal Anesthesia
NCT02037633
Fascia Iliaca Compartment Blocks for Pain Control in Hip Fractures
NCT04086914
Fascia Iliaca Compartment Blockade as Analgesia for Hip Fractures in the Acute Phase
NCT00162630
Blind Fascia Iliaca Compartment Block Compared to Ultrasound-guided Femoral Nerve Block in Patients With Hip Fractures
NCT05365555
Optimization of Analgesia for Hip Fracture Patients
NCT03609645
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fascia Iliaca Block Cohort
Prospective patients receiving fascia iliaca blocks A prospective Observational study of Hip fracture patients that are offered fascia iliaca blocks as standard of care in the ED.
Observational
Retrospective Control Cohort
No fascia iliaca block performed A retrospective review will be done of hip fracture patients that did not receive fascia iliaca blocks (before fascia iliaca blocks being offered in the ED as standard of care).
Retrospective review
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observational
Retrospective review
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 65+
* intact cognition upon admission and ability to provide written informed consent
Exclusion Criteria
* high energy fractures
* concomitant fractures besides hip fractures
* chronic home opioid exposure prior to hospitalization
* moderate to severe dementia
* pre-fracture hospitalization
* time from arrival to block \>6 hours
* time from arrival to OR \<6 hours or \>48 hours
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Grand Rapids Medical Education Partners
OTHER
Spectrum Health Hospitals
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matthew Flannigan, MD
Role: PRINCIPAL_INVESTIGATOR
ECS
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-160
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.